HS-10382

HS-10382 · Jiangsu Hansoh Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS-10382, covering 2024-07-31 to 2024-07-31. Get the full timeline:

Most recent: Clinical Trial Update: Study of HS-10382 Combination in Patients With Chronic Myeloid Leukemia (CML) [Phase 1]